Home/Filings/4/0001209191-23-005795
4//SEC Filing

Cahill Brian Joseph 4

Accession 0001209191-23-005795

CIK 0000827871other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 6:21 PM ET

Size

4.9 KB

Accession

0001209191-23-005795

Insider Transaction Report

Form 4
Period: 2023-01-30
Cahill Brian Joseph
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2023-01-30$33.21/sh601$19,95930,871 total
Footnotes (1)
  • [F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1
  • filerCIK 0001831591

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:21 PM ET
Size
4.9 KB